SLC1A3 and cancer: Altogether, we conclude that the transcriptomic changes (Fig 4A–C) are in concordance with metabolomic perturbations (Figs 3E and EV2F) and cellular outcomes (Fig 3A–C), indicating a novel role of SLC1A3 in cancer cell survival following ASNase treatment.